Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Aether Holdings, Inc. announced the acquisition of a 60% interest in Noviant, a technology services company with expertise in enterprise infrastructure, cloud, cybersecurity, and managed IT services. This acquisition strengthens Aether Compute's AI infrastructure strategy by integrating Noviant's deployment, management, and support services, positi…
CoreCivic, Inc. has entered into a $500 million accelerated share repurchase agreement as part of its expanded $755.8 million share repurchase program. The transaction is expected to reduce weighted average shares outstanding, enhancing per share metrics. Following the ASR agreement, CoreCivic updated its 2026 financial guidance, raising diluted EP…
Cogent Biosciences reports significant progress in 2026 including the submission of multiple New Drug Applications for bezuclastinib targeting Gastrointestinal Stromal Tumors (GIST) and Systemic Mastocytosis, a strong cash position of $865.9 million, and full onboarding of a specialized commercial team ahead of potential FDA approvals later this ye…
Credicorp Ltd., a leading Peruvian financial services holding company listed on the NYSE as BAP, announced its earnings release for the second quarter of 2026 scheduled for August 13, with a follow-up conference call on August 14 featuring key executives. The company also referenced its recently filed 2025 Annual Report with audited financials unde…
Telomir Pharmaceuticals announced publication of peer-reviewed preclinical data demonstrating their drug candidate Telomir-Zn suppresses tumor growth in triple-negative breast cancer (TNBC) and prostate cancer models by modulating intracellular iron and copper to inhibit KDM histone demethylases. The selective targeting of iron-dependent cancer cel…
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on oral delivery of biologics, announced that its management team will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026. The company will present and hold one-on-one meetings to discuss its proprietary oral biologics delivery platform, …
Alvotech, a global biotechnology company specializing in biosimilar medicines, will report its financial results for the first half of 2026 on August 19, followed by a webcast and live Q&A on August 20. The company focuses on developing and manufacturing biosimilars and has multiple products approved and marketed globally, with strategic partnershi…
Standard Lithium Ltd. reported strong second quarter 2026 results, marked by completion of major milestones including receiving a Finding of No Significant Impact (FONSI) from the U.S. Department of Energy under NEPA for its South West Arkansas Project (SWA Project), and execution of two critical construction contracts. These achievements position …
California Resources Corporation (NYSE: CRC) announced an agreement to acquire Crimson Midstream Holdings for approximately $63 million to strengthen its integrated midstream energy infrastructure platform in California. The acquisition includes about 2,000 miles of pipelines with capacity of 400 thousand barrels per day, improving CRC's ability to…
Spyre Therapeutics announced the launch of its SPY772 program, a dual long-acting antibody combination targeting TL1A and IL-17A/F for Hidradenitis Suppurativa (HS). The company has initiated the randomized Phase 2 SKYLIGHT trial to evaluate the clinical proof-of-concept of this dual inhibition approach, aiming to improve efficacy and convenience o…
BitFuFu Inc., a leading Bitcoin mining company listed on NASDAQ under ticker FUFU, announced it will release its unaudited financial results for the second quarter ended June 30, 2026, before the US market opens on August 17, 2026. The company will host an earnings conference call the same day. BitFuFu specializes in Bitcoin mining and mining servi…
Blue Owl has been punished with headline risk and heavy short interest, but its underlying economics - $1.32B in free cash flow, a $19B market cap, and a dividend supported by recurring fee income - argue for a constructive trade. This is a tactical long: enter near current levels, protect with a defined stop, and target meaningful upside as flows …
XPO, Inc., a leading North American freight transportation company, has appointed Jonas Svedlund as its new Chief Legal Officer. Svedlund brings significant legal expertise from his previous roles at Thermo Fisher Scientific and General Electric, and will oversee legal, compliance, corporate governance, and commercial matters at XPO.
Assured Guaranty (AGO) has tumbled into oversold territory after a heavy session that left the shares near the 52-week low. Fundamentals remain intact: ~$3.3B market cap, P/E below 10, price-to-book around 0.6 and a modest quarterly dividend. This trade targets a mean-reversion recovery toward $85 while keeping a tight stop under recent support.
Standard Chartered has started coverage on Chainlink’s LINK token, assigning a $200 target for the end of 2030. The bank’s digital assets research head links the forecast to anticipated growth in tokenization and decentralized finance, and models steep increases in oracle and platform fee revenue that would support significant appreciation in LINK’…
Sandisk plunged after guiding conservatively and prioritizing long-term contracts worth roughly $93.9 billion. The market punished near-term growth misses; we see a tradeable long where consensus is overly focused on the cycle and is underweight the value of multi-year contracted revenue and strong cash generation. Entry at current levels, tight st…
Agnico Eagle combines scale, a steady dividend and a diversified asset base across high-quality deposits. At a market cap of ~$103.8B and a trailing PE of ~12.6, the stock looks fairly valued for a top-tier producer and still has room to run toward $220 with continued gold strength and steady operational execution. Technical momentum is bullish, bu…
Berkshire reported solid operating earnings growth, increased repurchases and continues to generate meaningful free cash flow. At roughly $1.12T market cap and a P/E near 15.5, the stock offers a conservative equity exposure with management buying back shares aggressively. I lay out a mid-term trade with explicit entry, stop and target, plus the ke…
Meta's free cash flow has softened relative to its size, leaving the stock stretched on a P/FCF basis. Still, the company is doubling down on AI and infrastructure with capex guidance that should boost ad targeting and monetization over the next 12-18 months. This trade idea buys that optionality at $604.01, uses a $540 stop, and targets $720 over …
Autozi Internet Technology's Hong Kong subsidiary intends to acquire significant economic exposure to SpaceX through a fund or similar vehicle as a strategic treasury asset. The transaction is pending due diligence, financing, and approvals. Autozi aims to enhance shareholder value by diversifying into innovative global technology assets like Space…
Oruka Therapeutics announced solid second quarter financial results with a strong cash position of $1.1 billion, enabling funding through a Biologics License Application (BLA) filing for ORKA-001. The company advanced key clinical programs including positive Phase 2a data for ORKA-001 in plaque psoriasis, full enrollment in EVERLAST-B Phase 2b tria…
Ceribell, Inc., a medical technology firm specializing in neurological diagnostics, announced FDA 510(k) clearance for two new AI-driven features—Epileptiform Abnormality Detection and Artifact Reduction—integrated into its cloud-based Neurology Portal. These enhancements improve the accuracy and efficiency of EEG evaluations in critical care setti…
Jade Biosciences announced encouraging second quarter 2026 financial results and significant clinical updates including positive interim Phase 1 data for JADE101 in IgA nephropathy, initiation of Phase 2 and planned Phase 3 trials, and progress with JADE201 and JADE301 programs targeting autoimmune diseases. The company reported a robust cash posit…
Tonix Pharmaceuticals Holding Corp. reported a significant 197% increase in net sales of TONMYA in Q2 2026, reaching approximately $11 million. Coverage now includes about 136 million U.S. lives, with further expansion expected in managed Medicare starting January 2027. The company initiated a Phase 2 study for TNX-102 SL in major depressive disord…
Shopify posted 34% revenue growth and a tripling of AI-driven orders in Q2, reaffirming its role as the infrastructure layer for modern commerce. The platform's GMV scale, recurring merchant revenue, and expanding services mix justify paying up, but the stock trades at premium multiples. This trade targets a breakout above the 52-week high with a d…
